Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Orthofix Medical Inc.
Report date October 31, 2019 · Filed November 04, 2019
Section 16 reporting ended · disclosed 2019-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 159,899 |
Reported balance
After 2019-10-31 transaction · row 1
1 source rowRow 1 · 2019-10-31 · Tax withholding · Disposed 5,142 · Balance 159,899 F1: Shares withheld by the Company to satisfy tax withholding requirements related to the vesting of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Company to satisfy tax withholding requirements related to the vesting of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2019 Filed Nov 4, 2019 21:14 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 5,142 | $42.03 | $216,118.26 |
DisclosureSEC source: 0001209191-19-054878 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,899 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements related to the vesting of restricted stock. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 21:11 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 5,805 | $50.97 | $295,874.46 |
DisclosureSEC source: 0001209191-19-047732 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,041 F1 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $51.09, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 1,493 | $51.84 | $77,397.12 |
DisclosureSEC source: 0001209191-19-042100 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,846 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 1,741 | $52.27 | $91,002.07 |
DisclosureSEC source: 0001209191-19-042100 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,339 Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 21:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionPerformance Share Units · Derivative | 18,150 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-041720 · doc4.xml · derivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,150 shares Expires 2019-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 1, 2016, the reporting person was granted 36,300 performance stock units that, to the extent earned, settle as common stock based on the Company's total shareholder return ("TSR"), in relation to the TSR of companies included within the S&P Healthcare Select Sector Index as of July 1, 2016, during the performance period of July 1, 2016 through June 28, 2019. On July 8, 2019 (the "Vesting Date"), the compensation committee of the Company's board of directors determined that the awards were achieved at 50% of target, resulting in 18,150 shares of common stock being earned by the reporting person. Under the terms of the award, delivery of the earned shares of common stock will be deferred until one year following the Vesting Date. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 21:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 18,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-041720 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 1, 2016, the reporting person was granted 36,300 performance stock units that, to the extent earned, settle as common stock based on the Company's total shareholder return ("TSR"), in relation to the TSR of companies included within the S&P Healthcare Select Sector Index as of July 1, 2016, during the performance period of July 1, 2016 through June 28, 2019. On July 8, 2019 (the "Vesting Date"), the compensation committee of the Company's board of directors determined that the awards were achieved at 50% of target, resulting in 18,150 shares of common stock being earned by the reporting person. Under the terms of the award, delivery of the earned shares of common stock will be deferred until one year following the Vesting Date. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:52 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,123 | $51.44 | $160,638.38 |
DisclosureSEC source: 0001209191-19-037407 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,930 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F3 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.315 to $51.91, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:52 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 5,767 | $50.93 | $293,688.51 |
DisclosureSEC source: 0001209191-19-037407 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,053 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.31 to $51.31, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:21 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 300 | $54.41 | $16,323.99 |
DisclosureSEC source: 0001209191-19-030364 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,820 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F3 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.24 to $54.59, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:21 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 10,368 | $53.69 | $556,638.22 |
DisclosureSEC source: 0001209191-19-030364 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,120 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.21 to $54.16, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 17, 2019 Filed Apr 19, 2019 15:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,749 | $52.52 | $196,897.48 |
DisclosureSEC source: 0001209191-19-025331 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,488 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F3 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.38 to $53.36, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| April 17, 2019 Filed Apr 19, 2019 15:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 2,200 | $52.07 | $114,546.74 |
DisclosureSEC source: 0001209191-19-025331 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,237 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.37 to $52.36, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 35,587 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023365 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,437 F1 · shares: Represents time-based vesting restricted stock units that vest on the first anniversary of the grant date, April 1, 2019. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:11 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 13,141 | $57.06 | $749,825.46 |
DisclosureSEC source: 0001209191-19-019136 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,850 Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:11 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 16,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019136 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,991 Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,200 | $50.00 | $160,000.00 |
DisclosureSEC source: 0001209191-19-003953 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,401 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,800 | $50.37 | $90,664.74 |
DisclosureSEC source: 0001209191-19-003953 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,601 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.76, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 26, 2018 Filed Dec 28, 2018 21:04 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 9,440 | $51.52 | $486,348.80 |
DisclosureSEC source: 0001209191-18-064314 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,401 Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:05 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 2,500 | $53.02 | $132,554.50 |
DisclosureSEC source: 0001209191-18-050036 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,841 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.88 to $53.29, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 22:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 300 | $55.14 | $16,542.99 |
DisclosureSEC source: 0001209191-18-046092 · doc4.xml · nonDerivative · entry 4 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,341 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.12 to $55.16, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 22:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 500 | $53.95 | $26,977.00 |
DisclosureSEC source: 0001209191-18-046092 · doc4.xml · nonDerivative · entry 3 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,641 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.63 to $54.43, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 22:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,400 | $53.02 | $74,225.06 |
DisclosureSEC source: 0001209191-18-046092 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,141 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.46 to $53.37, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 22:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 300 | $51.41 | $15,423.00 |
DisclosureSEC source: 0001209191-18-046092 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,541 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.14 to $51.79, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 20:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 2,500 | $58.62 | $146,553.75 |
DisclosureSEC source: 0001209191-18-042332 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,290 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.18 to $59.04, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 20:03 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 2,500 | $57.95 | $144,863.50 |
DisclosureSEC source: 0001209191-18-038018 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,221 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.84 to $58.20, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 37,102 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023260 · doc4.xml · derivative · entry 3 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,102 Underlying: Common Stock · 37,102 shares Expires 2021-04-02 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 2, 2018 to April 2, 2021. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 2, 2018, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 65,857 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001209191-18-023260 · doc4.xml · derivative · entry 2 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,857 Underlying: Common Stock · 65,857 shares Expires 2028-04-02 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 18,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023260 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,572 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 21:35 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 5,000 | $53.48 | $267,400.00 |
DisclosureSEC source: 0001209191-17-063033 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,053 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:56 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 2,733 | $48.10 | $131,457.30 |
DisclosureSEC source: 0001209191-17-049973 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,053 Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:00 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 30,369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044655 · doc4.xml · derivative · entry 3 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,369 Underlying: Common Stock · 30,369 shares Expires 2020-07-03 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as July 3, 2017 to July 3, 2020. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of July 3, 2017, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:00 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 52,990 | $0.00 Strike: $46.10 | $0.00 |
DisclosureSEC source: 0001209191-17-044655 · doc4.xml · derivative · entry 2 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,990 Underlying: Common Stock · 52,990 shares Expires 2027-07-03 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:00 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 15,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044655 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,786 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:40 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionStock Option (right to buy) · Derivative | 6,667 | $0.00 Strike: $44.97 | $0.00 |
DisclosureSEC source: 0001209191-17-042017 · doc4.xml · derivative · entry 3 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,667 shares Expires 2017-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:40 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 6,555 | $46.32 | $303,627.60 |
DisclosureSEC source: 0001209191-17-042017 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,867 Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:40 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 6,667 | $44.97 | $299,814.99 |
DisclosureSEC source: 0001209191-17-042017 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 22:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,538 | $36.84 | $167,194.44 |
DisclosureSEC source: 0001209191-16-149393 · doc4.xml · nonDerivative · entry 2 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,681 F1 · kind: The sale of the shares reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on September 15, 2016. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.56 to $36.41, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 22:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 5,000 | $36.81 | $184,072.50 |
DisclosureSEC source: 0001209191-16-149393 · doc4.xml · nonDerivative · entry 1 Mason Brad · CIK 0001572153 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,219 F1 · kind: The sale of the shares reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on September 15, 2016. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $36.63, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.